Equip yourself with the latest treatment recommendations in endocrinology with the live session recordings from Clinical Endocrinology Update (CEU) 2019. Thought-leaders presented a comprehensive case-based program, providing practical recommendations that can be directly applied to your daily practice.
Plus, earn credits! CEU 2019 session recordings are certified for up to 28.50 AMA PRA Category 1 Credits™.
Topics/Speaker:
- Adrenal Cushing Diagnosis and Management
- Adrenal Incidentaloma Challenging Cases
- Adrenal Questions and Answers
- Challenges in the Evaluation and Management of Hypoglycemia
- Challenges of Managing Paraganglioma and Pheochromocytoma
- Challenging Cases in Lipid Management
- Clinical Update on Thyroid and Pregnancy
- Closing Remarks
- Contemporary Management of T1D in Pregnancy
- Controversies in the Treatment of Women with Menopausal Hormones
- Cushing’s Disease Update on Treatment
- Diabetes on a Budget
- Diagnosis and Management of Adrenal Insufficiency
- Diagnosis and Management of Hyponatremia
- Drug Holidays What patients and what drugs
- Fracture Healing
- From T to Z The Basics of Bone Density Interpretation
- Glycemic Management after Bariatric Surgery
- Helping Patients Find Motivation for Lifestyle Change
- HRT for Women
- Hypogonadal Cases
- Hypophysitis Etiology and Management
- Molecular Markers in the Workup of Thyroid Nodules
- Overview of Rare Bone Disease
- PCOS Treatment
- Premenopausal Osteoporosis
- Prolactinomas Special Topics
- Revisiting Old Drugs for T2D
- Risk Stratification in Thyroid Cancer
- Safety of Novel Agents in T2D Management
- Testosterone Replacement Modalities Pros, Cons and their Correct Use
- The New Cholesterol Management Guidelines
- Treatment of Diabetes in the Elderly
- Treatment Options for Advanced Thyroid Cancer
- Unusual Thyroid Function Tests Cases to Panelists
- Update on Diabetic Nephropathy
- Welcome and Introductions 1
- Welcome and Introductions 2
- Welcome and Introductions
- When Not to Use Testosterone in Men
Reviews
There are no reviews yet.